Emclaire Financial Corp Reports 11.9% Increase in Quarterly

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
170
Emclaire Financial Corp Reports 11.9% Increase in Quarterly Earnings

EMLENTON, Pa., July 21, 2017 (GLOBE NEWSWIRE) -- Emclaire Financial Corp (NASDAQ: EMCF ), the parent holding company of The Farmers National Bank of Emlenton, reported consolidated net income of $1.0 million, or $0.48 per share, for the three months ended June 30, 2017, an increase of $111,000, or 11.9%, from $930,000, or $0.43 per share, reported for the same period in 2016.  Net income for the six-month period ended June 30, 2017 was $2.0 million, or $0.92 per diluted share, an increase of $265,000, or 15.3%, from $1.7 million, or $0.80 per diluted share, for the same period in 2016.

The increase in net income for both periods was primarily driven by growth in loans outstanding, which led to increases in net interest income of 10.4% and 12.2% for the current quarter and year-to-date period, respectively.  Partially offsetting this increase were increases in noninterest expense, the provision for loan losses and the provision for income taxes.  The Corporation realized an annualized return on average assets of 0.58% and an annualized return on average equity of 7.50% for the quarter ended June 30, 2017, compared to 0.56% and 6.90%, respectively, for the same period in 2016.

William C. Marsh, Chairman, President and Chief Executive Officer of the Corporation and the Bank, noted, “The Board of Directors, management and I are pleased with the results for the first half of 2017, including strong earnings and balance sheet growth. We realized significant loan production and deposit growth across our franchise and are experiencing favorable results in the new offices in the Allegheny County market.  Efforts in the upcoming quarters will be focused on continued expansion through the completion of the acquisition of Northern Hancock Bank and Trust Co. (NHBT) in Chester, West Virginia.  We remain focused on sustaining a sound capital base while providing an attractive return to our shareholders and are well-positioned for future profitable growth.”

OPERATING RESULTS OVERVIEW

Net income increased $111,000, or 11.9%, to $1.0 million or $0.48 per common share for the three months ended June 30, 2017, compared to $930,000 or $0.43 per common share for the same period in 2016. The increase resulted from an increase in net interest income of $505,000, partially offset by a $74,000 decrease in noninterest income and increases in noninterest expense, the provision for loan losses and the provision for income taxes of $213,000, $80,000 and $27,000, respectively.

Net interest income increased $505,000, or 10.4%, to $5.4 million for the three months ended June 30, 2017 from $4.9 million for the same period in 2016.  The increase in net interest income resulted from an increase in interest income of $555,000, or 9.4%, primarily due to a $66.5 million increase in the average balance of loans.  Partially offsetting the increase in interest income, interest expense increased $50,000, or 4.9%, as the Corporation’s average balance of interest-bearing deposits and borrowed funds increased $33.3 million and $2.9 million, respectively.  Driving the increases in the Corporation’s interest-earning assets and interest-bearing liabilities was the acquisition of United-American Savings Bank (UASB) in late April 2016, which added $66.1 million in loans and $72.7 million in deposits to the Corporation.  In addition, the Bank experienced strong loan production in 2016 and through the first half of 2017.

The provision for loan losses increased $80,000, or 66.1%, to $201,000 for the three months ended June 30, 2017 from $121,000 for the same period in 2016 due to general increases in the Corporation's loan portfolio.  Asset quality continues to be strong as the Corporation's nonperforming loans and criticized and classified asset levels have both decreased.  Nonperforming loans decreased $278,000, or 8.4%, to $3.0 million at June 30, 2017 compared to $3.3 million at December 31, 2016, due primarily to the payoff of two residential mortgage loans totaling $391,000 which were on nonaccrual status. Criticized and classified assets decreased $3.1 million, or 24.2%, to $9.7 million at June 30, 2017 compared to $12.8 million at December 31, 2016, due primarily to the risk rating upgrade of one commercial loan relationship.

Noninterest income decreased $74,000, or 7.9%, to $868,000 for the three months ended June 30, 2017 from $942,000 for the same period in 2016.  During the quarter ended June 30, 2017, the Corporation recorded a $508,000 other-than-temporary impairment charge on a subordinated debt investment issued by First NBC Bank Holding Company.  On April 28, 2017, the Louisiana Office of Financial Institutions closed First NBC Bank, the wholly owned banking subsidiary of First NBC Bank Holding Company, and named the FDIC as receiver for the bank.  Partially offsetting this impairment charge, the Corporation realized securities gains of $350,000 during the quarter ended June 30, 2017, compared to $81,000 during the same period in 2016.  Additionally, gains on the sale of loans totaled $124,000 for the quarter ended June 30, 2017 and customer service fees increased $49,000 as overdraft charges for the second quarter of 2017 outpaced the same quarter last year.

Noninterest expense increased $213,000, or 4.8%, to $4.7 million for the quarter ended June 30, 2017 from $4.5 million for the same period in 2016.  The increase related to increases in compensation and benefits, premises and equipment, professional fees, acquisition costs, federal deposit insurance and intangible asset amortization of $170,000, $34,000, $26,000, $14,000, $13,000 and $3,000, respectively.  These increases in expenses were primarily related to normal salary and benefit increases and the operation of two new full-service banking offices: the South Side office which was acquired from UASB in April 2016 and the new Aspinwall office which opened in August 2016.  Partially offsetting these increases, other noninterest expense decreased $47,000.

The provision for income taxes increased $27,000 or 9.4%, to $314,000 for the three months ended June 30, 2017 from $287,000 for the same period in 2016.  This related to an increase in the Corporation's taxable income, partially offset by a decrease in the Corporation’s effective tax rate to 23.2% for the second quarter of 2017 from 23.6% for the same period in 2016.

CONSOLIDATED YEAR-TO-DATE OPERATING RESULTS OVERVIEW

Net income increased $265,000, or 15.3%, to $2.0 million or $0.92 per diluted share for the six months ended June 30, 2017, compared to $1.7 million or $0.80 per diluted share for the same period in 2016. The increase resulted from an increase in net interest income of $1.1 million, partially offset by increases in noninterest expense, the provision for loan losses and the provision for income taxes of $816,000, $61,000 and $3,000, respectively.

Net interest income increased $1.1 million, or 12.2%, to $10.5 million for the six months ended June 30, 2017 from $9.4 million for the same period in 2016.  The increase in net interest income resulted from an increase in interest income of $1.4 million, or 12.3%, as the Corporation experienced an $81.6 million increase in the average balance of loans.  Partially offsetting the increase in interest income, interest expense increased $235,000, or 12.7%, as the Corporation's average balance of interest-bearing deposits and borrowed funds increased $54.0 million and $5.5 million, respectively.  The increases in the Corporation's interest-earning assets and interest-bearing liabilities primarily relate to the aforementioned acquisition of UASB and strong loan and deposit production across the Bank's franchise.

The provision for loan losses increased $61,000, or 20.2%, to $363,000 for the six months ended June 30, 2017 from $302,000 for the same period in 2016 due to general increases in the Corporation's loan portfolio.

Noninterest income was $1.7 million for the six month periods ended June 30, 2017 and 2016.  During the six months ended June 30, 2017, the Corporation recorded the aforementioned $508,000 other-than-temporary impairment charge.  Partially offsetting this impairment charge, the Corporation realized securities gains of $350,000 during the six months ended June 30, 2017, compared to $83,000 during the same period in 2016.  Additionally, gains on the sale of loans totaled $130,000 for the six months ended June 30, 2017 and customer service fees increased $111,000 as overdraft charges for the first half of 2017 outpaced the same period last year.

Noninterest expense increased $816,000, or 9.6%, to $9.3 million for the six months ended June 30, 2017 from $8.5 million for the same period in 2016.  The increase related to increases in other noninterest expense, compensation and benefits, premises and equipment, professional fees, federal deposit insurance and intangible asset amortization of $473,000, $445,000, $106,000, $44,000, $28,000 and $14,000, respectively, partially offset by a $294,000 decrease in acquisition costs.  These increases in expenses were primarily related to the operation of two new full-service banking offices as well as normal salary and benefit increases.  During the six months ended June 30, 2017, the Corporation realized costs of $107,000 related to the acquisition of NHBT, compared to $401,000 of costs related to the acquisition of UASB during the same period in 2016.

CONSOLIDATED BALANCE SHEET & ASSET QUALITY OVERVIEW

Total assets increased $44.7 million, or 6.5%, to $736.9 million at June 30, 2017 from $692.1 million at December 31, 2016.  Asset growth was driven by increases in net loans receivable and cash and equivalents of $30.3 million and $17.1 million, respectively.  Liabilities increased $42.2 million, or 6.6%, to $680.2 million at June 30, 2017 from $638.1 million at December 31, 2016 due to an increase in customer deposits of $44.2 million.

Total nonperforming assets were $3.3 million, or 0.44% of total assets at June 30, 2017 compared to $3.6 million, or 0.52% of total assets at December 31, 2016. This $363,000, or 10.0%, decrease in nonperforming assets was primarily due to the payoff of two residential mortgage loans on nonaccrual status totaling $391,000.

Stockholders’ equity increased $2.6 million, or 4.8%, to $56.6 million at June 30, 2017 from $54.1 million at December 31, 2016 primarily due to proceeds from the exercise of stock options of $1.3 million and net income of $2.0 million for the six month period, offset by common stock dividends paid of $1.2 million. The Corporation remains well capitalized and is positioned for continued growth with total stockholders’ equity at 7.7% of total assets.  Tangible book value per common share was $20.86 at June 30, 2017, compared to $20.08 at December 31, 2016.

Emclaire Financial Corp is the parent company of The Farmers National Bank of Emlenton, an independent, nationally chartered, FDIC-insured community bank headquartered in Emlenton, Pennsylvania, operating 17 full service banking offices in Venango, Allegheny, Butler, Clarion, Clearfield, Crawford, Elk, Jefferson and Mercer counties, Pennsylvania.  The Corporation’s common stock is quoted on and traded through the NASDAQ Capital Market under the symbol “EMCF”.  For more information, visit the Corporation’s website at “ www.emclairefinancial.com ”.

This news release may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements may contain words such as “believe”, “expect”, “anticipate”, “estimate”, “should”, “may”, “can”, “will”, “outlook”, “project”, “appears” or similar expressions.  Such forward-looking statements are subject to risk and uncertainties which could cause actual results to differ materially from those currently anticipated due to a number of factors. Such factors include, but are not limited to, changes in interest rates which could affect net interest margins and net interest income, the possibility that increased demand or prices for the Corporation's financial services and products may not occur, changing economic and competitive conditions, technological and regulatory developments, and other risks and uncertainties, including those detailed in the Corporation's filings with the Securities and Exchange Commission.  The Corporation does not undertake, and specifically disclaims any obligation to update any forward-looking statements to reflect occurrences or unanticipated events or circumstances after the date of such statements.

EMCLAIRE FINANCIAL CORP  
Consolidated Financial Highlights  
(Unaudited - Dollar amounts in thousands, except share data)  
       
CONSOLIDATED OPERATING RESULTS DATA: Three month period   Six month period  
      ended June 30,   ended June 30,  
        2017     2016     2017     2016  
Interest income $ 6,432     $ 5,877     $ 12,605     $ 11,226    
Interest expense   1,067       1,017       2,084       1,849    
  Net interest income     5,365       4,860       10,521       9,377    
Provision for loan losses   201       121       363       302    
Noninterest income   868       942       1,723       1,722    
Noninterest expense   4,677       4,464       9,298       8,482    
  Income before provision for income taxes     1,355       1,217       2,583       2,315    
Provision for income taxes   314       287       586       583    
  Net income   $ 1,041     $ 930     $ 1,997     $ 1,732    
                                             
Basic earnings per common share $ 0.48     $ 0.43     $ 0.93     $ 0.81    
Diluted earnings per common share $ 0.48     $ 0.43     $ 0.92     $ 0.80    
Dividends per common share $ 0.27     $ 0.26     $ 0.54     $ 0.52    
Return on average assets (1)   0.58 %     0.56 %     0.57 %     0.54 %  
Return on average equity (1)   7.50 %     6.90 %     7.31 %     6.47 %  
Yield on average interest-earning assets   3.94 %     3.86 %     3.94 %     3.88 %  
Cost of average interest-bearing liabilities   0.82 %     0.84 %     0.81 %     0.81 %  
Cost of funds   0.66 %     0.67 %     0.65 %     0.64 %  
Net interest margin   3.30 %     3.21 %     3.30 %     3.24 %  
Efficiency ratio   76.75 %     75.09 %     75.47 %     74.00 %  
____________________                
(1) Returns are annualized for the three and six month periods ended June 30, 2017 and 2016.  
           
CONSOLIDATED BALANCE SHEET DATA:   As of   As of  
              6/30/2017   12/31/2016  
Total assets         $ 736,865     $ 692,135    
Cash and equivalents           34,715       17,568    
Securities           99,828       101,560    
Loans, net           545,766       515,435    
Deposits           629,174       584,940    
Borrowed funds           41,500       44,000    
Stockholders' equity           56,647       54,073    
Book value per common share         $ 25.74     $ 25.12    
Tangible book value per common share         $ 20.86     $ 20.08    
Net loans to deposits           86.74 %     88.13 %  
Allowance for loan losses to total loans           1.05 %     1.06 %  
Nonperforming assets to total assets           0.44 %     0.52 %  
Stockholders' equity to total assets           7.69 %     7.81 %  
Shares of common stock outstanding           2,200,944       2,152,358    
                         

INVESTOR RELATIONS CONTACT: William C. Marsh Chairman, President and Chief Executive Officer Phone: (844) 800-2193 Email: investor.relations@farmersnb.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

SKK Holdings Limited Announces Pricing for Share IPO Offering

Updated Category News Views 65

SKK Holdings Limited Announces Share Pricing for IPO SKK Holdings Limited (“SKK” or the “Company”) (Nasdaq: SKK), a specialized civil engineering service provider in subsurface utility works, has proudly announced the pricing of its initial public offering. The Company will offer 2,500,000 ordinary shares at a public offering price of $4.00 per share, yielding...

Continue Reading
Antelope Enterprise: Financial Performance Insights for 2024

Updated Category News Views 149

Antelope Enterprise Holdings Limited (NASDAQ: AEHL) hit the financial report stage hard back in mid-2024, flaunting numbers that tell quite the tale of both triumphs and tribulations. This company was hustling across two growing fronts: the fast-paced world of livestreaming ecommerce and the burgeoning energy sector down in Texas. Their half-year performance review...

Continue Reading
Olivier Falut Steps Into CFO Role at EUROAPI to Drive Growth

Updated Category News Views 344

Olivier Falut Joins EUROAPI as the New Chief Financial Officer EUROAPI is excited to announce the appointment of Olivier Falut as its new Chief Financial Officer, effective immediately. Olivier will be an integral member of the Executive Committee, succeeding Evelyne Nguyen. Evelyne will ensure continuity and a smooth transition within the company through her support...

Continue Reading
OPEXUS and Casepoint Join Forces for Growth and Innovation

Updated Category News Views 261

OPEXUS and Casepoint Unite for Strategic Growth In a significant development in the technology sector, OPEXUS, a frontrunner in government process management software, and Casepoint, an innovator in data discovery technology, have announced their merger. This significant move comes along with a majority investment from Thoma Bravo, a renowned software investment firm...

Continue Reading
MeiraGTx Holdings: An In-Depth Look at Future Potential

Updated Category News Views 69

MeiraGTx Holdings plc (NASDAQ:MGTX) was a clinical-stage gene therapy firm making waves back in 2024. The company announced a pivotal financial move, securing $50 million through equity financing at $4 per share, largely thanks to a $30 million investment from Sanofi (NYSE:SNY). While this funding boosted MGTX’s war chest, traders were already whispering about the heavy...

Continue Reading